Labcorp to Speak at the Baird 2024 Global Healthcare Conference
Labcorp to Speak at the Baird 2024 Global Healthcare Conference
BURLINGTON, N.C., Sept. 3, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a presentation at the Baird 2024 Global Healthcare Conference on Tuesday, September 10, at 3:10 p.m. ET.
全球領先的創新型和綜合性實驗室服務提供商Labcorp（紐交所：LH）今天宣佈，公司的高管團隊成員將參加貝爾德2024全球醫療保健大會，演講時間爲9月10日下午3:10（Eastern Time）.
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 67,000 employees serve clients in approximately 100 countries, provided support for 84% of the new drugs and therapeutic products approved in 2023 by the FDA and performed more than 600 million tests for patients around the world. Learn more about us at .
關於Labcorp
Labcorp（紐交所：LH）是一家全球領先的創新型和綜合性實驗室服務提供商，幫助醫生、醫院、藥品公司、研究人員和患者做出明確和自信的決策。我們通過獨一無二的診斷和藥物研發實驗室能力，提供洞察力並推動科學進步，改善健康並提高生活質量。該公司的逾67,000名員工爲約100個國家的客戶提供服務，爲美國食品藥品監督管理局在2023年批准的84%新藥和治療產品提供支持，併爲全球患者進行了逾60000萬個測試。了解更多信息，請訪問網站。
SOURCE Labcorp Holdings Inc
Labcorp Holdings Inc的消息來源
譯文內容由第三人軟體翻譯。